Skip to main content

Table 2 Comparison of native T1 values between patients with myocardial disease or coronary artery disease and control group

From: Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice

Group Mid LV short-axis native T 1 (ms) Group Septum native T1 (ms)
Mean ± SD 95% CI p-value Mean ± SD 95% CI p-value
Amyloidosis (n = 11) 1426 ± 57 1392–1460 < 0.001 Amyloidosis (n = 11) 1441 ± 72 1393–1490 < 0.001
DCM (n = 157) 1341 ± 52 1333–1349 < 0.001 DCM (n = 157) 1349 ± 59 1340–1358 < 0.001
HCM (n = 112) 1333 ± 56 1323–1344 < 0.001 HCM (n = 112) 1345 ± 59 1334–1356 < 0.001
Myocarditis (n = 17) 1344 ± 62 1315–1374 0.004 Myocarditis (n = 17) 1355 ± 56 1327–1384 0.002
CAD (n = 293) 1316 ± 51 1310–1322 < 0.001 CAD (n = 247) 1328 ± 54 1321–1334 < 0.001
Control (n = 595) 1294 ± 37 1291–1297   Control (n = 638) 1304 ± 42 1301–1308  
  1.  A p-value < 0.05 indicates statistical significance
  2. SD standard deviation, CI confidence interval, DCM dilated cardiomyopathy, HCM hypertrophic cardiomyopathy, CAD coronary artery disease